![Boundless Bio Inc](/common/images/company/N_BOLD.png)
The current BOLD market cap is 90.8M. The company's latest EPS is USD -2.2213 and P/E is -1.84.
Quarter End | Mar 2024 |
---|---|
USD ($) | |
Total Revenue | 0 |
Operating Income | -16.88M |
Net Income | -15.43M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Revenue | 0 |
Operating Income | -54.8M |
Net Income | -49.43M |
Quarter End | Mar 2024 |
---|---|
USD ($) | |
Total Assets | 117.08M |
Total Liabilities | 10.64M |
Total Equity | -141.18M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 129.89M |
Total Liabilities | 9.36M |
Total Equity | -127.08M |
Market Cap | 90.8M |
Price to Earnings Ratio | -1.84 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.83 |
Price to Book Ratio | 0.75 |
Dividend Yield | - |
Shares Outstanding | 22.25M |
Average Volume (1 week) | 48.04k |
Average Volume (1 Month) | 140.4k |
52 Week Change | -71.37% |
52 Week High | 15.20 |
52 Week Low | 3.75 |
Spread (Intraday) | 1.05 (22.68%) |
Company Name | Boundless Bio Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.boundlessbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.